Establishment of the Aging and Neurodegeneration Integrated Review Group, 39442 [2023-12987]
Download as PDF
<![CDATA[
39442
Federal Register / Vol. 88, No. 116 / Friday, June 16, 2023 / Notices
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carmen Bertoni, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 805B,
Bethesda, MD 20892, (301) 867–5309,
bertonic2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 13, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–12979 Filed 6–15–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
Establishment of the Aging and
Neurodegeneration Integrated Review
Group
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
1001–1014), the Director, National
Institutes of Health (NIH) announces the
establishment of the Aging and
Neurodegeneration Integrated Review
Group (IRG) as authorized by 42 U.S.C.
282(b)(16), section 402(b)(16) of the
Public Health Service Act, as amended.
The Director, NIH, has determined
that the Aging and Neurodegeneration
IRG is in the public interest in
connection with the performance of
duties imposed on NIH by law, and that
these duties can best be performed
through the advice and counsel of the
committee.
This committee provides advice and
recommendations on funding
applications and proposals, including
but not limited to, the scientific and
technical merit of applications for
grants-in-aid for research, research
training, or research-related grants and
cooperative agreements, or contract
proposals relating to scientific areas
relevant to aging and
neurodegeneration.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or Claire.Harris@nih.gov.
VerDate Sep<11>2014
17:43 Jun 15, 2023
Jkt 259001
Dated: June 13, 2023.
Lawrence A. Tabak,
Acting NIH Director, National Institutes of
Health.
[FR Doc. 2023–12987 Filed 6–15–23; 8:45 am]
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
BILLING CODE 4140–01–P
[Docket ID FEMA–2023–0002; Internal
Agency Docket No. FEMA–B–2348]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Changes in Flood Hazard
Determinations
National Institutes of Health
AGENCY:
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel; Office of Research Infrastructure
Programs (ORIP): Applications for Scientific
Conferences.
Date: July 12, 2023.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
0229, kenneth.ryan@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: June 13, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–12978 Filed 6–15–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
Management Agency (FEMA) for each
community, is appropriate because of
new scientific or technical data. The
FIRM, and where applicable, portions of
the FIS report, have been revised to
reflect these flood hazard
determinations through issuance of a
Letter of Map Revision (LOMR), in
accordance with Federal Regulations.
The currently effective community
number is shown in the table below and
must be used for all new policies and
renewals.
SUMMARY:
These flood hazard
determinations will be finalized on the
dates listed in the table below and
revise the FIRM panels and FIS report
in effect prior to this determination for
the listed communities.
From the date of the second
publication of notification of these
changes in a newspaper of local
circulation, any person has 90 days in
which to request through the
community that the Deputy Associate
Administrator for Insurance and
Mitigation reconsider the changes. The
flood hazard determination information
may be changed during the 90-day
period.
DATES:
The affected communities
are listed in the table below. Revised
flood hazard information for each
community is available for inspection at
both the online location and the
respective community map repository
address listed in the table below.
Additionally, the current effective FIRM
and FIS report for each community are
accessible online through the FEMA
ADDRESSES:
E:\FR\FM\16JNN1.SGM
16JNN1
]]>Agencies
[Federal Register Volume 88, Number 116 (Friday, June 16, 2023)]
[Notices]
[Page 39442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12987]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Establishment of the Aging and Neurodegeneration Integrated
Review Group
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. 1001-1014), the Director, National Institutes of Health (NIH)
announces the establishment of the Aging and Neurodegeneration
Integrated Review Group (IRG) as authorized by 42 U.S.C. 282(b)(16),
section 402(b)(16) of the Public Health Service Act, as amended.
The Director, NIH, has determined that the Aging and
Neurodegeneration IRG is in the public interest in connection with the
performance of duties imposed on NIH by law, and that these duties can
best be performed through the advice and counsel of the committee.
This committee provides advice and recommendations on funding
applications and proposals, including but not limited to, the
scientific and technical merit of applications for grants-in-aid for
research, research training, or research-related grants and cooperative
agreements, or contract proposals relating to scientific areas relevant
to aging and neurodegeneration.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: June 13, 2023.
Lawrence A. Tabak,
Acting NIH Director, National Institutes of Health.
[FR Doc. 2023-12987 Filed 6-15-23; 8:45 am]
BILLING CODE 4140-01-P
